212 related articles for article (PubMed ID: 19969013)
21. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors.
Tamiz AP; Bandyopadhyay BC; Zhang J; Flippen-Anderson JL; Zhang M; Wang CZ; Johnson KM; Tella S; Kozikowski AP
J Med Chem; 2001 May; 44(10):1615-22. PubMed ID: 11334571
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms underlying the rewarding effects of cocaine.
Hall FS; Sora I; Drgonova J; Li XF; Goeb M; Uhl GR
Ann N Y Acad Sci; 2004 Oct; 1025():47-56. PubMed ID: 15542699
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
Han DD; Gu HH
BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
[TBL] [Abstract][Full Text] [Related]
26. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
[TBL] [Abstract][Full Text] [Related]
27. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
[TBL] [Abstract][Full Text] [Related]
28. Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice.
Perles-Barbacaru TA; Procissi D; Demyanenko AV; Hall FS; Uhl GR; Jacobs RE
Neuroimage; 2011 Mar; 55(2):622-8. PubMed ID: 21185387
[TBL] [Abstract][Full Text] [Related]
29. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
[TBL] [Abstract][Full Text] [Related]
30. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Yamashita M; Fukushima S; Shen HW; Hall FS; Uhl GR; Numachi Y; Kobayashi H; Sora I
Neuropsychopharmacology; 2006 Oct; 31(10):2132-9. PubMed ID: 16407898
[TBL] [Abstract][Full Text] [Related]
31. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
32. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.
Haenisch B; Bönisch H
Pharmacol Ther; 2011 Mar; 129(3):352-68. PubMed ID: 21147164
[TBL] [Abstract][Full Text] [Related]
33. Serotonin transporter inhibition and 5-HT
Stewart A; Davis GL; Gresch PJ; Katamish RM; Peart R; Rabil MJ; Gowrishankar R; Carroll FI; Hahn MK; Blakely RD
Neuropsychopharmacology; 2019 Apr; 44(5):994-1006. PubMed ID: 30578419
[TBL] [Abstract][Full Text] [Related]
34. Oligomerization of Monoamine Transporters.
Paul A; Shukla D
Subcell Biochem; 2024; 104():119-137. PubMed ID: 38963486
[TBL] [Abstract][Full Text] [Related]
35. The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice.
Thanos PK; Michaelides M; Benveniste H; Wang GJ; Volkow ND
Synapse; 2008 May; 62(5):319-24. PubMed ID: 18286542
[TBL] [Abstract][Full Text] [Related]
36. Possible role of norepinephrine in cocaine-induced conditioned taste aversions.
Serafine KM; Riley AL
Pharmacol Biochem Behav; 2009 Mar; 92(1):111-6. PubMed ID: 19027784
[TBL] [Abstract][Full Text] [Related]
37. Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.
O'Neill B; Tilley MR; Han DD; Thirtamara-Rajamani K; Hill ER; Bishop GA; Zhou FM; During MJ; Gu HH
Neuropharmacology; 2014 Apr; 79():626-33. PubMed ID: 24412674
[TBL] [Abstract][Full Text] [Related]
38. Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII.
Steinkellner T; Montgomery TR; Hofmaier T; Kudlacek O; Yang JW; Rickhag M; Jung G; Lubec G; Gether U; Freissmuth M; Sitte HH
J Neurosci; 2015 May; 35(21):8258-71. PubMed ID: 26019340
[TBL] [Abstract][Full Text] [Related]
39. Cell-type-specific expression of catecholamine transporters in the rat brain.
Lorang D; Amara SG; Simerly RB
J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459
[TBL] [Abstract][Full Text] [Related]
40. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
